B. Riley FBR Reinstates Buy on Acasti Pharma, Announces $8 Price Target

B. Riley FBR reinstates Acasti Pharma (NASDAQ:ACST) with a Buy and announces $8 price target.

Benzinga · 11/18/2019 16:03

B. Riley FBR reinstates Acasti Pharma (NASDAQ:ACST) with a Buy and announces $8 price target.